Lantheus Holdings (LNTH) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $1.55
- Estimate
- $1.30
- Surprise
- +18.9%
- Revenue (period 2026-06-30)
- $388.2M
- Score at report (before → after)
- 6.6 → 6.5/10
Revenue source: xbrl.
How the report landed
Lantheus Holdings (LNTH) beat the $1.30 estimate with diluted EPS of $1.55 — a large 18.9% upside surprise. TrendMatrix's engine moved from Hold (6.6/10) to Sell at 6.5/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates LNTH Hold at 6.2/10.
3 of the last 4 quarters beat the estimate; this quarter's +18.9% surprise compares with a +20.2% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.5 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Supplier: sole suppliers (synthesis boxes, lipid blend)
- Analyst target reached - limited upside remaining
- Earnings estimates trending DOWN
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $100.95
- Price target
- $116.09
- Stop
- $99.86
- Upside to target
- +15.0%
The stock trades at 24.1× trailing but 16.0× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
LNTH at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - Specialty & Generic
- Market cap
- $6.59B
- P/E (fwd)
- 16.0
- P/E (ttm)
- 24.1
- 52-week range
- $49.67–$111.86
- Off 52-week high
- 9.8%
- RSI (14)
- 50
- Volume vs avg
- 0.49×
- Score today
- 6.2/10